147 related articles for article (PubMed ID: 28854352)
1. Screening of "spice" herbal mixtures: From high-field to low-field proton NMR.
Assemat G; Dubocq F; Balayssac S; Lamoureux C; Malet-Martino M; Gilard V
Forensic Sci Int; 2017 Oct; 279():88-95. PubMed ID: 28854352
[TBL] [Abstract][Full Text] [Related]
2. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.
Banister SD; Stuart J; Kevin RC; Edington A; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2015 Aug; 6(8):1445-58. PubMed ID: 25921407
[TBL] [Abstract][Full Text] [Related]
3. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: a snapshot of the German situation in the autumn of 2012.
Langer N; Lindigkeit R; Schiebel HM; Ernst L; Beuerle T
Drug Test Anal; 2014; 6(1-2):59-71. PubMed ID: 23723183
[TBL] [Abstract][Full Text] [Related]
4. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.
Ibáñez M; Bijlsma L; van Nuijs AL; Sancho JV; Haro G; Covaci A; Hernández F
J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959
[TBL] [Abstract][Full Text] [Related]
5. Quantification of synthetic cannabinoids in herbal smoking blends using NMR.
Dunne SJ; Rosengren-Holmberg JP
Drug Test Anal; 2017 May; 9(5):734-743. PubMed ID: 27400773
[TBL] [Abstract][Full Text] [Related]
6. Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures.
Alves VL; Gonçalves JL; Aguiar J; Caldeira MJ; Teixeira HM; Câmara JS
Anal Bioanal Chem; 2021 Mar; 413(8):2257-2273. PubMed ID: 33575815
[TBL] [Abstract][Full Text] [Related]
7. Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.
Canazza I; Ossato A; Vincenzi F; Gregori A; Di Rosa F; Nigro F; Rimessi A; Pinton P; Varani K; Borea PA; Marti M
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597570
[TBL] [Abstract][Full Text] [Related]
8. Synthetic cannabinoids in e-liquids: A proton and fluorine NMR analysis from a conventional spectrometer to a compact one.
Wu N; Danoun S; Balayssac S; Malet-Martino M; Lamoureux C; Gilard V
Forensic Sci Int; 2021 Jul; 324():110813. PubMed ID: 33993010
[TBL] [Abstract][Full Text] [Related]
9. Identification and quantification of synthetic cannabinoids in "spice-like" herbal mixtures: Update of the German situation for the spring of 2016.
Langer N; Lindigkeit R; Schiebel HM; Papke U; Ernst L; Beuerle T
Forensic Sci Int; 2016 Dec; 269():31-41. PubMed ID: 27863282
[TBL] [Abstract][Full Text] [Related]
10. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: Update of the German situation in summer 2018.
Ernst L; Langer N; Bockelmann A; Salkhordeh E; Beuerle T
Forensic Sci Int; 2019 Jan; 294():96-102. PubMed ID: 30497049
[TBL] [Abstract][Full Text] [Related]
11. Identification of Eight Synthetic Cannabinoids, Including 5F-AKB48 in Seized Herbal Products Using DART-TOF-MS and LC-QTOF-MS as Nontargeted Screening Methods.
Moore KN; Garvin D; Thomas BF; Grabenauer M
J Forensic Sci; 2017 Sep; 62(5):1151-1158. PubMed ID: 28597943
[TBL] [Abstract][Full Text] [Related]
12. Synthetic cannabinoids as designer drugs: new representatives of indol-3-carboxylates series and indazole-3-carboxylates as novel group of cannabinoids. Identification and analytical data.
Shevyrin V; Melkozerov V; Nevero A; Eltsov O; Baranovsky A; Shafran Y
Forensic Sci Int; 2014 Nov; 244():263-75. PubMed ID: 25305529
[TBL] [Abstract][Full Text] [Related]
13. Analysis of synthetic cannabinoids in "spice-like" herbal highs: snapshot of the German market in summer 2011.
Simolka K; Lindigkeit R; Schiebel HM; Papke U; Ernst L; Beuerle T
Anal Bioanal Chem; 2012 Jul; 404(1):157-71. PubMed ID: 22710567
[TBL] [Abstract][Full Text] [Related]
14. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
[TBL] [Abstract][Full Text] [Related]
15. Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073.
Cooper ZD; Poklis JL; Liu F
Neuropharmacology; 2018 May; 134(Pt A):92-100. PubMed ID: 29146503
[TBL] [Abstract][Full Text] [Related]
16. CBL-2201. Report on a new designer drug: Napht-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate.
Kondrasenko AA; Goncharov EV; Dugaev KP; Rubaylo AI
Forensic Sci Int; 2015 Dec; 257():209-213. PubMed ID: 26386336
[TBL] [Abstract][Full Text] [Related]
17. Mass spectral studies on 1-n-pentyl-3-(1-naphthoyl)indole (JWH-018), three deuterium-labeled analogues and the inverse isomer 1-naphthoyl-3-n-pentylindole.
Thaxton A; Belal TS; Smith F; DeRuiter J; Abdel-Hay KM; Clark CR
Rapid Commun Mass Spectrom; 2015 May; 29(9):871-7. PubMed ID: 26377015
[TBL] [Abstract][Full Text] [Related]
18. Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in 'herbal incense'.
Kneisel S; Westphal F; Bisel P; Brecht V; Broecker S; Auwärter V
J Mass Spectrom; 2012 Feb; 47(2):195-200. PubMed ID: 22359329
[TBL] [Abstract][Full Text] [Related]
19. Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.
Seely KA; Patton AL; Moran CL; Womack ML; Prather PL; Fantegrossi WE; Radominska-Pandya A; Endres GW; Channell KB; Smith NH; McCain KR; James LP; Moran JH
Forensic Sci Int; 2013 Dec; 233(1-3):416-22. PubMed ID: 24314548
[TBL] [Abstract][Full Text] [Related]
20. Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135.
De Luca MA; Castelli MP; Loi B; Porcu A; Martorelli M; Miliano C; Kellett K; Davidson C; Stair JL; Schifano F; Di Chiara G
Neuropharmacology; 2016 Jun; 105():630-638. PubMed ID: 26686391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
